Sage Journals: Discover world-class research

Abstract

Objective

To compare outcomes between patients who underwent preoperative non-invasive testing and those who did not prior to all-level lower extremity amputation (LEA).

Methods

A retrospective analysis of patients undergoing LEA between April 1st 2019 and June 30th 2023 at an acute care facility was performed and relevant demographic and perioperative data collected. The primary endpoint was the association of preoperative non-invasive testing on MALE and MACE.

Results

188 patients who underwent all-level LEA were included and stratified into two groups: those who had preoperative non-invasive testing (52.7%; n = 99; p < .01) and those who did not (Groups A and B, respectively). Group A demonstrated higher minority representation (p = .04), pre-existing vascular disease (p < .01), hypertension (p < .01), and renal and cardiac comorbidities (both p < .01).

Chi-squared analysis between groups demonstrated no significant difference in all-level LEA for outcomes of postoperative revascularization (p = .63), re-amputation (major or all-level; p = .98 and p = .78, respectively), nor any differences in wound complications (p = .79) or mortality (p = .37). In sub-analyses for major and minor amputations, there remained no significant differences in major re-amputation (p = .69 and p = .27, respectively), 30-day wound complications (p = .44 and p = .65, respectively), or MACE (p = .50 and p = .93, respectively) between groups.

Conclusions

Authors note infrequent use of non-invasive testing prior to LEA, and similar MALE and MACE outcomes between groups with potential benefit in medically vulnerable cohorts. With a lack of established guidelines on preoperative workup prior to LEA, additional prospective studies with matched cohorts and similar endpoints may promote algorithms to optimize perioperative outcomes.

Keywords

Amputation lower extremity amputation non-invasive testing MALE MACE outcomes

Get full access to this article

View all access options for this article.

References

Owings

Kozak

. Ambulatory and inpatient procedures in the United States. Vital Health Stat 13. 1998;(139):1-119.

Dillingham

Pezzin

Shore

. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil 2005; 86(3): 480–486.

Foussard

Dari

Ducasse

, et al. Lower-limb peripheral arterial disease and amputations in people with diabetes: risk factors, prognostic value and management. Presse Med 2023; 52(1): 104164.

Jolissaint

Shah

Martin

, et al. Risk prediction of 30-day mortality after lower extremity major amputation. J Vasc Surg 2019; 70(6): 1868–1876.

Thorud

Plemmons

Buckley

, et al. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg 2016; 55(3): 591–599.

Eslami

Zayaruzny

Fitzgerald

. The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg 2007; 45(1): 55–59.

Arya

Binney

Khakharia

, et al. Race and Socioeconomic status independently affect risk of major amputation in peripheral artery disease. J Am Heart Assoc 2018; 7(2): e007425.

Barnes

Eid

Creager

, et al. Epidemiology and risk of amputation in patients with diabetes Mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol 2020; 40(8): 1808–1817.

Hirsch

Haskal

Hertzer

, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the acc/aha task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; transatlantic inter-society consensus; and vascular disease foundation. Circulation 2006; 113(11): e463–e654.

10.

Norvell

Suckow

Webster

, et al. The development and usability of the ampredict decision support tool: a mixed methods study. Eur J Vasc Endovasc Surg 2021; 62(2): 304–311.

11.

Swaminathan

Vemulapalli

Patel

, et al. Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag 2014; 10: 417–424.

12.

Torbjörnsson

Blomgren

Fagerdahl

, et al. Risk factors for amputation are influenced by competing risk of death in patients with critical limb ischemia. J Vasc Surg 2020; 71(4): 1305–1314.

13.

Abry

Weiss

Makaloski

, et al. Peripheral artery disease leading to major amputation: trends in revascularization and mortality over 18 years. Ann Vasc Surg 2022; 78: 295–301.

14.

Tan

Calhoun

Knapp

, et al. Rates of diabetes-related major amputations among racial and ethnic minority adults following medicaid expansion under the patient protection and affordable care act. JAMA Netw Open 2022; 5(3): e223991.

15.

Divakaran

Krawisz

Secemsky

, et al. Sex and racial disparities in peripheral artery disease. Arterioscler Thromb Vasc Biol 2023; 43(11): 2099–2114.

16.

Shamir

Schwartz

Cohen

, et al. The timing of limb amputation in nontraumatic patients: impact on mortality and postoperative complication rates. J Foot Ankle Surg 2022; 61(2): 293–297.

17.

Hardy

Lyden

. The majority of patients have diagnostic evaluation prior to major lower extremity amputation. Ann Vasc Surg 2019; 58: 78–82.

18.

Arsenault

Al-Otaibi

Devereaux

, et al. The use of transcutaneous oximetry to predict healing complications of lower limb amputations: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2012; 43(3): 329–336.

19.

Anthony

Gillies

Iyer

, et al. The indirect impact of COVID-19 pandemic on lower extremity amputations - an Australian study. Vasc Health Risk Manag 2023; 19: 797–803.

The role of non-invasive vascular assessment prior to lower extremity amputation